PARSABIV (Amgen Inc)
Welcome to the PulseAid listing for the PARSABIV drug offered from Amgen Inc. This Calcium-sensing Receptor Agonist [EPC],Increased Calcium-sensing Receptor Sensitivity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amgen Inc |
| NON-PROPRIETARY NAME: | etelcalcetide |
| SUBSTANCE NAME: | ETELCALCETIDE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium-sensing Receptor Agonist [EPC],Increased Calcium-sensing Receptor Sensitivity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-04-03 |
| END MARKETING DATE: | 0000-00-00 |
PARSABIV HUMAN PRESCRIPTION DRUG Details:
| Item Description | PARSABIV from Amgen Inc |
| LABELER NAME: | Amgen Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/.5mL) |
| START MARKETING DATE: | 2017-04-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55513-740_4100ce15-06c6-425b-955c-de568d81371f |
| PRODUCT NDC: | 55513-740 |
| APPLICATION NUMBER: | NDA208325 |
Other ETELCALCETIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
